WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMGN past earnings growth

How has AMGN's earnings growth performed historically?
Company
13.02%
Industry
10.59%
Market
40.67%
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMGN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMGN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMGN past revenue growth

How has AMGN's revenue growth performed historically?
Company
1.91%
Industry
1.28%
Market
14.14%
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMGN earnings and revenue history

Current Revenue
$26.8B
Current Earnings
$7.6B
Current Profit Margin
28.2%
AMGN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

AMGN Return on Equity

Current Company
129.1%
Current Industry
37.4%
Current Market
-9.5%
AMGN's Return on Equity (129.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMGN announces earnings.

AMGN Return on Assets

Current Company
9%
Current Industry
9%
AMGN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMGN Return on Capital Employed

Current Company
15.25%
Current Industry
16.1%
AMGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMGN vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMGN$26.83B$14.82B$7.57B+2.85%+29.80%
PFE$68.54B$16.53B$10.48B+5.13%-14.38%
SNY$51.84B$16.76B$9.68B+4.01%+17.96%
BMY$44.94B$18.42B$8.29B+15.32%+34.86%
GILD$27.39B$10.74B$5.88B+4.22%+30.59%
View Top General Drug Manufacturer Stocks

AMGN earnings dates

Next earnings date
Jan 29, 2024

Amgen Earnings & Revenue FAQ

What were AMGN's earnings last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q3 2023 earnings per share (EPS) of $3.23, up 19.45% year over year. Total Amgen earnings for the quarter were $1.73 billion. In the same quarter last year, Amgen's earnings per share (EPS) was $4.01.

If you're new to stock investing, here's how to buy Amgen stock.

What was AMGN's earnings growth in the past year?

As of Q4 2023, Amgen's earnings has grown 13.02% year over year. This is 2.43 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.59%. Amgen's earnings in the past year totalled $7.57 billion.

What is AMGN's earnings date?

Amgen's earnings date is Invalid Date. Add AMGN to your watchlist to be reminded of AMGN's next earnings announcement.

What was AMGN's revenue last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q3 2023 revenue of $6.90 billion up 3.77% year over year. In the same quarter last year, Amgen's revenue was $6.65 billion.

What was AMGN's revenue growth in the past year?

As of Q4 2023, Amgen's revenue has grown 1.91% year over year. This is 0.63 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 1.28%. Amgen's revenue in the past year totalled $26.83 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.